Jinfiniti Biosciences company grows out of laboratory and clinical studies at bi13512209 A new biotech company has grown out of laboratory and studies at the Medical College of Georgia the goal of improving the diagnosis and treatment of diabetes and cancer

MEDomics Presents Clinical Experience MitoDx Test for Mitochondrial Dise bi13512209 The emerging consensus that the frequency of mitochondrial diseases childhood may be as frequent as all childhood cancers combined. Early diagnosis important, these conditions are especially common children and treatment can prevent serious complications or death

Seattle Genetics and Agensys, an Affiliate of Astellas, Announce Initiation o bi13512209 BOTHELL, Wash.----Seattle Genetics, Inc. and Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a phase I trial of ASG-5ME for the treatment of metastatic pancreatic cancer

Test could predict children T-cell ALL are best candidates for cli bi13512209 A genetic clue uncovered by Dana-Farber Cancer Institute scientists enables doctors to predict, for the first time, children T-cell acute lymphoblastic leukemia (T-ALL) are unlikely to benefit from standard chemotherapy for the disease and should therefore be among the first to receive new treatments future trials

CytRx Announces Substantial Progress Its Bafetinib Clinical Trials Program bi13512209 LOS ANGELES----CytRx Corporation , a biopharmaceutical company specializing oncology, announces progress program to evaluate the preliminary efficacy and safety of drug candidate bafetinib three oncology indications

Jinfiniti Biosciences company grows out of laboratory and clinical studies at bi13512209 A new biotech company has grown out of laboratory and studies at the Medical College of Georgia the goal of improving the diagnosis and treatment of diabetes and cancer

MEDomics Presents Clinical Experience MitoDx Test for Mitochondrial Dise bi13512209 The emerging consensus that the frequency of mitochondrial diseases childhood may be as frequent as all childhood cancers combined. Early diagnosis important, these conditions are especially common children and treatment can prevent serious complications or death

Seattle Genetics and Agensys, an Affiliate of Astellas, Announce Initiation o bi13512209 BOTHELL, Wash.----Seattle Genetics, Inc. and Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a phase I trial of ASG-5ME for the treatment of metastatic pancreatic cancer

Test could predict children T-cell ALL are best candidates for cli bi13512209 A genetic clue uncovered by Dana-Farber Cancer Institute scientists enables doctors to predict, for the first time, children T-cell acute lymphoblastic leukemia (T-ALL) are unlikely to benefit from standard chemotherapy for the disease and should therefore be among the first to receive new treatments future trials

CytRx Announces Substantial Progress Its Bafetinib Clinical Trials Program bi13512209 LOS ANGELES----CytRx Corporation , a biopharmaceutical company specializing oncology, announces progress program to evaluate the preliminary efficacy and safety of drug candidate bafetinib three oncology indications

New biotech company grows from MCG diabetes and genomic research bi13512209 ( Medical College of Georgia ) A new biotech company has grown out of laboratory and studies at the Medical College of Georgia the goal of improving the diagnosis and treatment of diabetes and cancer. Dr. Jin-Xiong She, director of the MCG Center for Biotechnology and Genomic Medicine, president and CEO of the new Jinfiniti Biosciences LLC, housed the MCG's Life Sciences ..

Nasal zinc gels may be associated loss of sense of smell, study finds bi13512209 An evaluation of 25 patients and a review of reports of , biological and experimental data suggest that over-the-counter, homeopathic nasal zinc therapies may be associated a reduced sense of smell, according to a new study

MDMA (Ecstasy) holds promise for chronic treatment-resistant PTSD bi13512209 MDMA (-3,4-methylenedioxymethamphetamine, also known as Ecstasy), may one day offer hope for individuals posttraumatic stress disorder (PTSD), even people for whom other treatments have failed. trial results out today the Journal of Psychopharmacology, published by SAGE, suggests that MDMA can be administered to subjects PTSD evidence of harm and could offer ..

Honda Cbr Accessories - Home